Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-5 WOUNDS B-Treatment of wounds and injuries contaminated by B agents
Projektleitung: Kircher Julia
Laufzeit: 01.11.2025 - 31.10.2028
Geldgeber: Europäische Kommission

Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-4 BIOMARKERS B-New biomarkers of infection by B threat agents
Projektleitung: Kircher Julia
Laufzeit: 01.11.2025 - 31.10.2028
Geldgeber: Europäische Kommission

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

24.11.2025:

Schnur, SSK; Devadathan, S; Moran, R; Harb, S; Toth, GG; Ruzsa, Z Novel Hydraulic-Assisted Unkinking of a Guide Catheter During PCI
JACC-CARDIOVASC INTE. 2025; 18(20): 2554-2557. Doi: 10.1016/j.jcin.2025.08.007
Web of Science PubMed FullText FullText_MUG

 

24.11.2025:

Witoslawska, A; Drechsler, C; Duarte, K; Girerd, N; Zannad, F; Rossignol, P; Kleber, ME; Scharnagl, H; Wanner, C; März, W; Laaksonen, R Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD
CLIN J AM SOC NEPHRO. 2025; Doi: 10.2215/CJN.0000000831
Web of Science FullText FullText_MUG

 

24.11.2025:

Zhang, D; Liebal, K; Marschik, PB The Unseen Richness of the Beginning.
Neurosci Biobehav Rev. 2025; 106479 Doi: 10.1016/j.neubiorev.2025.106479
PubMed FullText FullText_MUG

 

24.11.2025:

Macchi, C; Fichtner, I; Mohamed, T; Franchi, E; Rizzuto, AS; Pavanello, C; Gindlhuber, J; Nerini, S; Sirtori, CR; Osto, E; Carugo, S; Busnelli, M; Chiesa, G; Magnaghi, V; Corsini, A; Ruscica, M Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE^-/- mice.
Biomed Pharmacother. 2025; 193:118726 Doi: 10.1016/j.biopha.2025.118726
PubMed FullText FullText_MUG

 

24.11.2025:

Davies, MJ; Bajaj, HS; Broholm, C; Eliasen, A; Garvey, WT; le, Roux, CW; Lingvay, I; Lyndgaard, CB; Rosenstock, J; Pedersen, SD, , REDEFINE, 2, Study, Group Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.
N Engl J Med. 2025; 393(7):648-659 Doi: 10.1056/NEJMoa2502082
PubMed FullText FullText_MUG

 

24.11.2025:

Ballarin, RS; Lazzarin, T; Minicucci, MF; Azevedo, PS; Dos, Santos, Nunes, Nogueira, V; Schoberer, D; Hoedl, M; Eglseer, D Vegetarian and Vegan Diets and the Risk of Hip Fracture in Adults: A Systematic Review and Meta-analysis.
Nutr Rev. 2025; Doi: 10.1093/nutrit/nuaf241
PubMed FullText FullText_MUG

 

24.11.2025:

Scaramuzza, AE; Marigliano, M; Moser, O; Abate, Daga, F; Bombaci, B; Franceschi, R; Presti, DL; Moretti, C; Mozzillo, E; Musolino, G; Predieri, B; Rigamonti, A; Tiberi, V; Tinti, D; Toni, S; Rabbone, I, , MyLife, Loop, Study, Group Optimising the CamAPS FX automated insulin delivery system for exercise and complex meals in adolescents with type 1 diabetes: A prospective interventional study in a camp setting.
Diabetes Obes Metab. 2025; Doi: 10.1111/dom.70295
PubMed FullText FullText_MUG

 

24.11.2025:

Monschein, T; Untersteiner, H; Ponleitner, M; Krajnc, N; Zrzavy, T; Bsteh, G; Rommer, P; Kornek, B; Enzinger, C; Di, Pauli, F; Kraus, J; Guger, M; Leutmezer, F; Berger, T, , Austrian, MS, Treatment, Registry, (AMSTR) Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).
J Neurol. 2025; 272(12):774 Doi: 10.1007/s00415-025-13473-7 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

20.11.2025:

Hasiba-Pappas, S; Opriessnig, E; Nischwitz, SP; Winter, R; Mandal, P; Carnieletto, M; Kamolz, LP; Luze, H Optimizing Autologous Fat Grafting: A Systematic Review of Enhancement Strategies and Graft Survival.
Aesthet Surg J. 2025; Doi: 10.1093/asj/sjaf242
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.